Federal Register - July 29, 2021

Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.

Source: Federal Register

jbell on DSKJLSW7X2PROD with NOTICES

40844

Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
respond to requests for consultation, and to support the site-specific response actions conducted by ATSDR, as otherwise necessary.
DATES: Nominations from the Substance Priority List and/or additional substances must be received by August 30, 2021.
ADDRESSES: You may submit nominations, identified by Docket No.
ATSDR20210006 by any of the following methods:
Internet: Access the Federal eRulemaking portal at www.regulations.gov. Follow the instructions for submitting comments.
Mail: Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd.
NE, Mail Stop S1021, Atlanta, GA
303294027. Attn: Docket No. ATSDR
20210006.
Instructions: All submissions must include the agency name and docket number for this notice. All relevant comments will be posted without change. This means that no confidential business information or other confidential information should be submitted in response to this notice.
Refer to the section Submission of Nominations below for the specific information required.
FOR FURTHER INFORMATION CONTACT: For further information, please contact Kambria Haire, Agency for Toxic Substances and Disease Registry, Office of Innovation and Analytics, 1600
Clifton Rd. NE, Mail Stop S1021, Atlanta, GA 303294027, Email:
ATSDRToxProfileFRNs@cdc.gov; Phone:
18002324636.
SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization Act of 1986 SARA 42
U.S.C. 9601 et seq. amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 CERCLA or Superfund 42
U.S.C. 9601 et seq. by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency EPA with regard to hazardous substances most commonly found at facilities on the CERCLA National Priorities List NPL for more information, visit www.epa.gov/
superfund/superfund-nationalpriorities-list-npl. Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare Toxicological Profiles for each substance included on the Substance Priority List. This list identifies 275
hazardous substances found at NPL sites that ATSDR and EPA have determined pose the most significant current potential threat to human health.

VerDate Sep<11>2014

19:19 Jul 28, 2021

Jkt 253001

Substances to be evaluated for Toxicological Profile development: Each year, ATSDR develops a list of substances to be considered for Toxicological Profile development. The nomination process includes consideration of all substances on ATSDRs SPL, as well as other substances nominated by the public. For more information on ATSDRs SPL, visit www.atsdr.cdc.gov/SPL/.
Submission of nominations for Toxicological Profile development: This notice invites voluntary public nominations for substances included on the SPL and for substances not listed on the SPL. When nominating a non-SPL
substance, please include the rationale for the nomination. ATSDR will evaluate data and information associated with nominated substances and will determine the final list of substances to be chosen for Toxicological Profile development.
Substances will be chosen according to ATSDRs specific guidelines for selection. These guidelines can be found in the Selection Criteria, which may be accessed at www.atsdr.cdc.gov/
toxprofiles/guidance/ATSDR_TP_
Selection%20Criteria.pdf.
Donata Green, Acting Director, Office of Policy, Partnerships and Planning, Agency for Toxic Substances and Disease Registry.
FR Doc. 202116195 Filed 72821; 8:45 am BILLING CODE 416370P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and Disease Registry Docket No. ATSDR20210005

Availability of Six Draft Toxicological Profiles Agency for Toxic Substances and Disease Registry ATSDR, Department of Health and Human Services HHS.
ACTION: Notice with comment period.
AGENCY:

The Agency for Toxic Substances and Disease Registry ATSDR, within the Department of Health and Human Services HHS, announces the opening of a docket to obtain comments on drafts of six updated Toxicological Profiles: Acetone, Aldrin/Dieldrin, Chlorophenols, 3,3Dichlorobenzidine, Disulfoton, and Pentachlorophenol.

SUMMARY:

Written comments must be received on or before October 27, 2021.

DATES:

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

You may submit comments, identified by docket number ATSDR
20210005, by any of the following methods:
Federal eRulemaking Portal:
www.regulations.gov. Follow the instructions for submitting comments.
Mail: Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd.
NE, Mail Stop S1021, Atlanta, GA, 303294027. Attn: Docket No. ATSDR
20210005.
Instructions: All submissions must include the agency name and Docket Number. All relevant comments received will be posted without change to http regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to http www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Kambria Haire, Agency for Toxic Substances and Disease Registry, Office of Innovation and Analytics, 1600
Clifton Rd. NE, Mail Stop S1021, Atlanta, GA, 303294027, Email:
ATSDRToxProfileFRNs@cdc.gov; Phone:
18002324636.
SUPPLEMENTARY INFORMATION: ATSDR
has prepared drafts of six updated toxicological profiles based on availability of new health effects and other information since their initial release. All toxicological profiles issued as Drafts for Public Comment represent the result of ATSDRs evidence-based evaluations to provide important toxicological information on priority hazardous substances. ATSDR
is seeking public comments and additional information or reports on studies about the health effects of these six substances for review and potential inclusion in the profiles. ATSDR
considers key studies for these substances during the profile development process. This notice solicits any relevant, additional studies.
ATSDR will evaluate the quality and relevance of such data or studies for possible inclusion in the profile.
ADDRESSES:

Public Participation Interested persons or organizations are invited to participate by submitting written views, information, and data.
Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If
E:FRFM29JYN1.SGM

29JYN1

Riguardo a questa edizione

Federal Register - July 29, 2021

TitoloFederal Register

PaeseStati Uniti

Data29/07/2021

Conteggio pagine169

Numero di edizioni7802

Prima edizione14/03/1936

Ultima edizione25/06/2026

Scarica questa edizione

Altre edizioni

<<<Julio 2021>>>
DLMMJVS
123
45678910
11121314151617
18192021222324
25262728293031